Opioid Rehab Near You: MAT, Detox & Recovery Programs
Browse SAMHSA-listed opioid rehab programs across all 50 states — filter by MAT type (buprenorphine, methadone, naltrexone), level of care (OTP, OBOT, residential, IOP, telehealth), and insurance acceptance. MAT reduces opioid overdose deaths by more than 50% (NIDA), yet fewer than 20% of people with OUD receive it. Synthetic opioids (primarily fentanyl) drive ~75% of US opioid overdose deaths — CDC reports over 80,000 annually. After the 2023 MAT Act, any licensed prescriber can offer buprenorphine in office-based or telehealth settings.
Found 9,319 rehab centers specializing in opioid addiction across the United States.
Need Help Finding the Right Treatment Center?
Speak with a compassionate specialist now - 100% free & confidential
Find Opioid Treatment Centers Near You
Browse opioid treatment centers below. Filter by MAT availability, state, insurance, and level of care to find the right program for your recovery needs.
Showing 20 of 9319 results
CleanSlate Centers, located in Lawrence, MA, provides outpatient treatment for substance use, particularly with a focus on therapies involving methadone, buprenorphine, and naltrexone. Their approach includes motivational interviewing, strategies for preventing relapse, and counseling for substance use disorders. The facility prioritizes personalized care, accommodating both adults and young adults of various genders. CleanSlate Centers creates a nurturing atmosphere for individuals pursuing recovery from addiction, with an emphasis on high-quality care and customized treatment plans. For those requiring thorough substance use support, CleanSlate Centers is an excellent choice for individualized and impactful care.
CleanSlate Centers in Evansville, IN, specializes in outpatient treatment for substance use disorders, offering services such as methadone, buprenorphine, and naltrexone therapy. The center employs techniques like motivational interviewing, strategies for preventing relapse, and counseling tailored to substance use issues. CleanSlate Centers is dedicated to providing customized care for both adults and young adults of any gender, prioritizing individualized treatment plans to aid in the recovery process. With a strong emphasis on high-quality, evidence-based care, those in need of addiction support can access extensive resources at this center in Evansville, IN.
CleanSlate Centers located in Lynn, MA, provides outpatient services for substance use treatment, featuring programs with methadone, buprenorphine, or naltrexone options. This center emphasizes techniques such as motivational interviewing, relapse prevention, and counseling for substance use disorders. With a commitment to personalized care, it serves adults and young adults across all genders. CleanSlate Centers fosters a nurturing atmosphere for those in need of addiction support, prioritizing exceptional care through individualized treatment strategies. For those seeking a holistic method to address substance use issues in Lynn, MA, this facility offers customized programs aimed at aiding your recovery process.
CleanSlate Centers located in Muncie, IN, offers outpatient treatment for substance use issues, with a focus on therapies such as methadone, buprenorphine, or naltrexone. The center employs techniques like motivational interviewing and relapse prevention, alongside counseling for substance use disorders, to provide customized care. Programs are designed to meet the needs of both adults and young adults across all genders. Prioritizing individualized care, CleanSlate Centers in Muncie, IN, is dedicated to delivering effective support for individuals seeking help with addiction.
CleanSlate Centers, located in Louisville, KY, provides outpatient services for substance use recovery, featuring programs that include methadone/buprenorphine and naltrexone therapies. The center employs techniques such as motivational interviewing, relapse prevention strategies, and counseling for substance use disorders to deliver personalized treatment for adults and young adults, regardless of gender. CleanSlate Centers is dedicated to creating customized care plans that assist individuals in their recovery paths. Their focus on delivering high-quality, specialized care positions them as an essential option for those looking for thorough addiction support in a nurturing setting.
CleanSlate Centers located in Gilbert, AZ, provides outpatient programs for substance use treatment designed for both adults and young adults. This center emphasizes outpatient therapies including methadone/buprenorphine and naltrexone, employing techniques such as motivational interviewing, strategies for preventing relapse, and counseling for substance use disorders. Focused on personalized treatment, the facility serves both men and women, creating a nurturing and thorough environment conducive to recovery. Their dedication to delivering high-quality and individualized care establishes CleanSlate Centers as an excellent option for individuals in the Gilbert region who are in need of effective and empathetic addiction treatment solutions.
CleanSlate Centers located in Kenosha, WI, provides outpatient services for substance use disorders aimed at both adults and young adults. This center focuses on outpatient treatments using methadone, buprenorphine, or naltrexone and employs motivational interviewing techniques, relapse prevention strategies, and counseling specific to substance use issues. Care at this facility is customized to meet the distinct requirements of each client, ensuring a personalized treatment experience. CleanSlate Centers prioritizes an individualized approach, serving both males and females in need of high-quality addiction rehabilitation. If you are in search of tailored, evidence-based support on your recovery path, this center is committed to assisting you in achieving enduring sobriety.
CleanSlate Centers, located in Phoenix, AZ, specializes in outpatient treatment programs for adults and young adults dealing with substance abuse. The center offers a variety of treatment options, including methadone, buprenorphine, and naltrexone, utilizing methods like motivational interviewing and strategies for preventing relapse, along with counseling for substance use disorders. Emphasizing personalized care, this facility serves both men and women looking for thorough rehabilitation services. CleanSlate Centers is dedicated to providing high-quality support, helping individuals on their path to recovery from substance use challenges.
CleanSlate Centers, located in Phoenix, Arizona, provides outpatient treatment options for substance use disorders, specifically focusing on methadone, buprenorphine, and naltrexone therapies. The center employs techniques such as motivational interviewing and relapse prevention alongside counseling tailored to substance abuse issues, ensuring that each program is customized to fit individual needs. Catering to adults and young adults across all genders, CleanSlate Centers in Phoenix fosters a welcoming and supportive atmosphere for those on their recovery journey. With a commitment to high-quality care and individualized treatment strategies, this center stands out as a reliable option for effective rehabilitation.
CleanSlate Centers located in Hyannis, MA, offers outpatient treatment for substance use disorders, featuring options such as methadone/buprenorphine and naltrexone. The center employs motivational interviewing techniques along with relapse prevention methods and counseling tailored to substance use issues, ensuring that care is customized for each person. Catering to adults and young adults of all genders, CleanSlate Centers emphasizes high-quality treatment combined with a focus on personalized care. If you or someone close to you is in search of effective addiction support that is comprehensive and individualized, this facility in Hyannis could be the right choice for you.
CleanSlate Centers located in Indianapolis, IN, specializes in outpatient treatment for substance use disorders, emphasizing personalized care for both adults and young adults. This facility offers outpatient options such as methadone/buprenorphine and naltrexone therapies, incorporating techniques like motivational interviewing, strategies for preventing relapse, and counseling specifically for substance use issues. The center adopts a customized approach to meet the distinct needs of each client and serves both men and women in need of thorough addiction rehabilitation. CleanSlate Centers in Indianapolis is dedicated to providing high-quality care and guidance to assist individuals in their recovery process.
CleanSlate Centers located in Wilkes Barre, PA, provides outpatient treatment for substance use disorders utilizing proven methods such as motivational interviewing, relapse prevention strategies, and counseling specific to substance use issues. This center offers outpatient services for methadone, buprenorphine, or naltrexone treatments, emphasizing a customized approach for both adult and young adult clients, regardless of gender. With a strong focus on delivering quality care, CleanSlate Centers develops treatment plans tailored to the distinct requirements of each individual. If you are looking for targeted substance use treatment that emphasizes personalized attention and effective therapeutic practices, this Wilkes Barre facility may be an excellent option for your recovery.
CleanSlate Centers, located in Williamsport, PA, is a prominent outpatient facility dedicated to treating substance use disorders. This center provides outpatient services, including methadone/buprenorphine and naltrexone therapies, utilizing proven methods like motivational interviewing, relapse prevention strategies, and counseling for substance use issues. Committed to personalized care, it serves both adults and young adults across all gender identities. CleanSlate Centers fosters a nurturing atmosphere for individuals striving to conquer addiction, delivering exceptional care and tailored treatment strategies to support sustained recovery.
CleanSlate Centers located in Scranton, PA, specializes in outpatient treatment for substance use, utilizing therapies such as methadone, buprenorphine, and naltrexone. The center adopts motivational interviewing techniques, relapse prevention methods, and counseling for substance use disorders to assist clients. They prioritize a tailored approach, serving both adults and young adults across all genders. CleanSlate Centers in Scranton fosters a secure and welcoming atmosphere for individuals pursuing addiction recovery, committing to high-quality care and customized assistance during each step of the healing process.
Located in Anderson, IN, CleanSlate Centers provides outpatient services for those dealing with substance use issues, emphasizing personalized care for both adults and young adults. The center specializes in outpatient treatment options such as methadone, buprenorphine, and naltrexone, and employs techniques like motivational interviewing, relapse prevention strategies, and comprehensive counseling for substance use disorders. CleanSlate Centers is dedicated to crafting individualized plans for each patient, welcoming both men and women who are seeking effective addiction recovery solutions. By focusing on tailored treatment and proven therapeutic methods, this facility creates a nurturing space for individuals working towards their recovery journey.
CleanSlate Centers, located in Greenwood, IN, specializes in outpatient treatment for substance use disorders, offering options such as methadone, buprenorphine, or naltrexone. The center employs techniques like motivational interviewing and focuses on relapse prevention along with counseling for substance use issues. Emphasizing tailored care, CleanSlate Centers serves adults and young adults across all genders. The facility is committed to delivering high-quality, evidence-based treatments aimed at helping individuals on their recovery journey. For those in need of thorough addiction treatment within a nurturing environment, this center provides customized programs designed to support long-term sobriety.
CleanSlate Centers, located in Lexington, KY, is dedicated to providing outpatient treatment for substance use disorders, emphasizing personalized care. The center offers options such as methadone, buprenorphine, or naltrexone for adults and young adults, regardless of gender. By employing techniques like motivational interviewing and relapse prevention, along with counseling for substance use issues, the center aims to deliver thorough support on the path to recovery. Committed to customized treatment plans and a holistic perspective, CleanSlate Centers strives to offer exceptional care for those wishing to break free from addiction. For those seeking individualized assistance in a nurturing atmosphere, this facility is focused on promoting sustainable sobriety.
CleanSlate Centers, located in Noblesville, IN, specializes in outpatient treatment programs for substance abuse, concentrating on customized care. The center offers outpatient services with methadone, buprenorphine, or naltrexone for adults and young adults across all gender identities. By employing techniques such as motivational interviewing, strategies for preventing relapse, and counseling for substance use disorders, this facility creates personalized treatment plans to address the unique requirements of each client. Committed to delivering high-quality care, CleanSlate Centers in Noblesville distinguishes itself through its individualized approach to recovery, ensuring everyone receives the necessary support for achieving sustainable sobriety.
CleanSlate Centers, located in Philadelphia, PA, specializes in outpatient programs for substance use treatment designed for both adults and young adults of all genders. The center administers outpatient treatments with methadone, buprenorphine, or naltrexone, utilizing proven methods like motivational interviewing, relapse prevention, and counseling for substance use disorders. Emphasizing personalized care, CleanSlate Centers is committed to addressing the distinct needs of each individual to facilitate effective treatment. Patients can look forward to receiving exceptional, empathetic support from a team of skilled professionals focused on guiding individuals toward recovery.
CleanSlate Centers located in Dayton, OH, provides outpatient treatment for substance use disorders, emphasizing personalized care. This center offers treatment options such as methadone, buprenorphine, or naltrexone for both adults and young adults, regardless of gender. Employing strategies like motivational interviewing and relapse prevention, CleanSlate Centers customizes its programs to meet the distinct needs of each client. Dedicated to delivering high-quality care, this facility supports individuals in their recovery journey. For those in search of tailored addiction treatment that honors their personal experiences, CleanSlate Centers in Dayton could be the ideal option.
Opioid Use Disorder (OUD): Key Facts
Classification
Opioid Use Disorder (OUD)
Prevalence
2.1 million adults with OUD in the US (SAMHSA)
Overdose deaths
80,000+ opioid overdose deaths/year in US (CDC)
Primary substances
Fentanyl, heroin, oxycodone, hydrocodone
Gold standard treatment
Medication-Assisted Treatment (MAT)
MAT effectiveness
Reduces overdose deaths by 50%+ (NIDA)
FDA-approved medications
Buprenorphine (Suboxone), Methadone, Naltrexone (Vivitrol)
Emergency reversal
Naloxone (Narcan)
Opioid Overdose Emergency: Know the Signs
An opioid overdose can kill within minutes. If you see these signs, act immediately:
Overdose warning signs
- Blue or purple lips and fingernails (cyanosis)
- Pinpoint (extremely small) pupils
- Slow, shallow, or stopped breathing
- Unresponsive to shouting or sternal rub
- Gurgling or choking sounds
- Limp body, pale or clammy skin
What to do
- Call 911 immediately — most states have Good Samaritan laws protecting callers
- Administer naloxone (Narcan) if available — nasal spray or injection
- Perform rescue breathing — one breath every 5 seconds
- Place in recovery position (on their side) to prevent choking
- Give a second dose of naloxone after 2-3 minutes if no response
- Stay until help arrives — naloxone wears off in 30-90 minutes
National Overdose Prevention Hotline: 911 | SAMHSA Helpline: 1-800-662-4357 (24/7, free, confidential)
What Is Opioid Use Disorder?
DSM-5 diagnostic criteria
Opioid Use Disorder (OUD) is a chronic, relapsing brain condition defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It is diagnosed when a person meets at least two of eleven criteria within a 12-month period, including: taking opioids in larger amounts or for longer than intended, persistent desire or unsuccessful efforts to cut down, spending excessive time obtaining or using opioids, cravings, failure to fulfill major obligations, continued use despite social or interpersonal problems, giving up important activities, use in physically hazardous situations, continued use despite physical or psychological problems, tolerance, and withdrawal.
Severity classification
OUD severity is classified based on the number of criteria met: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). Severe OUD carries the highest risk of overdose death and typically requires the most intensive treatment, including medication-assisted treatment. Even mild OUD warrants professional intervention, as the disorder tends to progress without treatment.
Opioids vs. opiates
The term "opiates" refers specifically to natural compounds derived from the opium poppy (morphine, codeine). "Opioids" is the broader term that includes opiates plus semi-synthetic drugs (oxycodone, hydrocodone, heroin) and fully synthetic drugs (fentanyl, methadone, tramadol). All opioids bind to mu-opioid receptors in the brain, producing pain relief, euphoria, and respiratory depression — the mechanism that causes fatal overdoses.
The Opioid Epidemic: Fentanyl Crisis
Three waves of the opioid epidemic
The US opioid crisis has unfolded in three distinct waves. The first wave (1990s) was driven by aggressive marketing of prescription opioids — OxyContin, Vicodin, Percocet — leading doctors to overprescribe and millions of patients to develop dependence. The second wave (around 2010) saw a surge in heroin use as people with prescription opioid addiction shifted to cheaper, more accessible heroin. The third wave (2013-present) is defined by illicitly manufactured fentanyl and its analogs, which now account for the majority of opioid overdose deaths in the United States.
Why fentanyl changed everything
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine and approximately 50 times more potent than heroin. A lethal dose of fentanyl is just 2 milligrams — roughly the size of a few grains of salt. Because fentanyl is cheap to manufacture and extremely potent by weight, drug traffickers mix it into heroin, cocaine, methamphetamine, and counterfeit prescription pills. Many people who die from fentanyl overdoses did not know they were consuming it. Counterfeit pills made to look like oxycodone (M30), Xanax, or Adderall frequently contain lethal doses of fentanyl.
Current impact
According to the CDC, over 80,000 Americans die from opioid overdoses each year, with synthetic opioids (primarily illicit fentanyl) responsible for roughly 75% of those deaths. Opioid overdose is now the leading cause of accidental death for Americans under 50. The crisis affects every demographic, geographic region, and socioeconomic group in the country.
Opioid Withdrawal Timeline
Opioid withdrawal is intensely uncomfortable but rarely life-threatening on its own. The timeline varies depending on whether the person was using short-acting opioids (heroin, oxycodone, hydrocodone) or long-acting opioids (methadone, extended-release morphine).
Short-acting opioids (heroin, oxycodone)
- 6-12 hours: Onset of symptoms — anxiety, muscle aches, sweating, yawning, runny nose
- 24-48 hours: Escalation — insomnia, diarrhea, nausea, vomiting, abdominal cramps, dilated pupils
- 48-72 hours: Peak severity — intense cravings, body aches, goosebumps, rapid heartbeat
- 5-7 days: Acute symptoms begin to subside
- 1-2 weeks: Most physical symptoms resolve
Long-acting opioids (methadone, ER morphine)
- 24-48 hours: Delayed onset of symptoms
- 3-5 days: Symptoms escalate and peak
- 5-10 days: Peak and plateau of acute withdrawal
- 10-20 days: Gradual improvement of physical symptoms
- 2-3 weeks: Most acute symptoms resolve
Post-Acute Withdrawal Syndrome (PAWS)
After acute withdrawal resolves, many people experience Post-Acute Withdrawal Syndrome (PAWS) — a set of prolonged symptoms including anxiety, depression, insomnia, fatigue, difficulty concentrating, and mood swings that can persist for weeks to months. PAWS is the leading cause of relapse in the first year of recovery and is a key reason why ongoing treatment and support are essential after detox.
Why medical detox matters
While opioid withdrawal itself is rarely fatal, the extreme discomfort drives many people to relapse during detox — and relapse after a period of abstinence is when overdose risk is highest, because tolerance has decreased. Medically supervised detoxification uses medications like buprenorphine, clonidine, and comfort medications to manage symptoms safely, dramatically reducing relapse during the withdrawal period.
Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment is the gold standard for opioid use disorder, combining FDA-approved medications with counseling and behavioral therapies. Research from NIDA shows MAT reduces opioid overdose deaths by more than 50%, decreases illicit opioid use, reduces criminal activity, improves social functioning, and increases treatment retention. Despite this evidence, fewer than 20% of people with OUD receive MAT — a treatment gap that costs tens of thousands of lives each year.
Buprenorphine (Suboxone)
Type: Partial opioid agonist
Buprenorphine activates opioid receptors just enough to prevent withdrawal and cravings without producing the intense euphoria of full agonists. It has a "ceiling effect," meaning higher doses do not increase effects — significantly reducing overdose risk. Suboxone combines buprenorphine with naloxone to deter misuse.
Setting: Can be prescribed by any licensed prescriber in office-based settings (OBOT), pharmacies, or telehealth.
Methadone
Type: Full opioid agonist
Methadone is a long-acting opioid that stabilizes brain chemistry, eliminates withdrawal symptoms, and blocks the euphoric effects of other opioids at proper doses. It has the longest track record of any MAT medication, with over 50 years of evidence supporting its effectiveness.
Setting: Must be dispensed daily at a certified Opioid Treatment Program (OTP/methadone clinic). Take-home doses earned over time with compliance.
Naltrexone (Vivitrol)
Type: Opioid antagonist (blocker)
Naltrexone completely blocks opioid receptors, preventing any opioid from producing effects. The extended-release injection (Vivitrol) is administered monthly and eliminates the need for daily medication adherence. Unlike buprenorphine and methadone, naltrexone has no abuse potential and is not a controlled substance.
Requirement: Patient must be fully detoxed (7-14 days opioid-free) before starting naltrexone to avoid precipitated withdrawal.
MAT medication comparison
The three FDA-approved MAT medications differ in mechanism, dispensing model, and patient fit. The table below summarizes the key distinctions:
| Medication | Type | DEA Schedule | Setting | Dispensing | Best for |
|---|---|---|---|---|---|
| Buprenorphine (Suboxone, Sublocade, Subutex, Zubsolv, Brixadi) | Partial agonist with ceiling effect | III | OBOT, telehealth, retail pharmacy | Take-home from day 1 (or monthly injection) | Most patients; rural areas; daily clinic not feasible |
| Methadone | Full mu-opioid agonist | II | OTP only (42 CFR Part 8) | Daily at clinic → take-home after 90 days | Severe OUD; prior buprenorphine failure; long-standing dependence |
| Naltrexone (Vivitrol) | Opioid antagonist (blocker) | Not controlled | Any prescriber; injection at clinic | Monthly IM injection (380 mg) | Highly motivated; post-detox (7-14 days opioid-free); no abuse potential desired |
All three are effective; the best choice is the one the patient will actually take consistently. Adherence, not pharmacology, is the dominant predictor of outcomes. Buprenorphine and methadone are first-line for active opioid use; naltrexone requires complete detox before initiation.
Types of Opioid Treatment Programs
OTP / Methadone Clinics
Opioid Treatment Programs are federally certified clinics that dispense methadone and provide comprehensive services including counseling, drug testing, and case management. Patients visit daily initially, earning take-home privileges over time.
OBOT (Office-Based Treatment)
Office-Based Opioid Treatment allows any licensed prescriber to treat OUD with buprenorphine in a standard medical office or via telehealth. This model dramatically increases access, especially in rural areas with no OTPs. Patients fill prescriptions at regular pharmacies.
Residential (inpatient) programs provide 24/7 structured care for 30-90 days. Best for severe OUD, polysubstance use, co-occurring mental health disorders, or patients who need separation from their environment. Most residential programs offer MAT as part of treatment.
IOP programs provide 9-20 hours of structured treatment per week while allowing patients to live at home. Combines group therapy, individual counseling, and MAT. Effective for moderate OUD or as a step-down from residential treatment.
Standard outpatient involves 1-2 sessions per week — typically individual therapy and/or group sessions combined with MAT. Suitable for mild to moderate OUD or as a long-term maintenance level of care after completing more intensive treatment.
Medical detox provides 3-7 days of supervised withdrawal management using medications to ease symptoms. Detox alone is not treatment — it must be followed by ongoing MAT and/or behavioral therapy. Detox without continued care has very high relapse rates.
Naloxone: The Overdose Reversal Medication
What naloxone does
Naloxone (brand name Narcan) is an opioid antagonist that rapidly reverses opioid overdose by displacing opioids from receptors in the brain. It restores normal breathing within 2-5 minutes in most cases. Naloxone has no effect on people who do not have opioids in their system and has virtually no abuse potential. Since 2023, Narcan nasal spray is available over the counter at pharmacies nationwide without a prescription.
How to use naloxone nasal spray
Using Narcan nasal spray requires no medical training:
- Peel back the package and remove the device
- Tilt the person's head back and insert the nozzle into one nostril
- Press the plunger firmly to deliver the full dose
- If no response in 2-3 minutes, administer a second dose in the other nostril
- Continue rescue breathing and call 911 — naloxone wears off in 30-90 minutes, and the person may stop breathing again
Where to get naloxone for free
Many harm reduction organizations, health departments, and community pharmacies distribute naloxone for free or at low cost. SAMHSA's Opioid Overdose Prevention Toolkit and state naloxone access programs provide resources. Most states have standing orders allowing pharmacists to dispense naloxone without an individual prescription. If you or someone you know uses opioids, carrying naloxone can save a life.
Frequently Asked Questions About Opioid Treatment
What is medication-assisted treatment (MAT) for opioid addiction?
Medication-Assisted Treatment (MAT) combines FDA-approved medications — methadone, buprenorphine (Suboxone), or naltrexone (Vivitrol) — with counseling and behavioral therapies. These medications reduce cravings, prevent withdrawal symptoms, and normalize brain chemistry, allowing people to focus on recovery. MAT is the most effective treatment for opioid use disorder: it reduces overdose deaths by more than 50%, decreases illicit drug use, and improves treatment retention rates (NIDA).
How long does opioid withdrawal last?
The withdrawal timeline depends on the opioid used. Short-acting opioids like heroin and oxycodone cause symptoms within 6-12 hours that peak at 48-72 hours and subside over 5-7 days. Long-acting opioids like methadone produce delayed symptoms starting at 24-48 hours, peaking at 3-5 days, and lasting up to 2-3 weeks. Post-acute withdrawal symptoms (PAWS) — including anxiety, insomnia, and mood instability — may persist for weeks to months after acute withdrawal resolves.
Is buprenorphine (Suboxone) just replacing one addiction with another?
No — this is one of the most harmful misconceptions in addiction medicine. Buprenorphine is a partial opioid agonist prescribed at stable, controlled doses as part of comprehensive treatment. It does not produce euphoria when taken as directed, eliminates cravings, prevents withdrawal, and allows people to function normally — work, care for families, and rebuild their lives. Taking buprenorphine for OUD is no different than taking insulin for diabetes: it is evidence-based medication for a chronic medical condition.
What should I look for in an opioid treatment center?
Look for centers offering MAT options (buprenorphine, methadone, and/or naltrexone), accreditation from CARF or The Joint Commission, licensed medical staff experienced in addiction medicine, comprehensive assessment with individualized treatment plans, evidence-based therapies (CBT, contingency management), family support services, and strong aftercare planning. Verify they accept your insurance and offer the appropriate level of care for your situation.
Can I work while in opioid treatment?
Yes, especially with outpatient MAT programs. Outpatient treatment — including OBOT (office-based buprenorphine) and standard outpatient counseling — allows you to maintain work, family, and social responsibilities while receiving care. Intensive Outpatient Programs (IOP) typically meet 9-20 hours per week and can often be scheduled around work. Many employers are required to support recovery under the ADA and FMLA. Residential treatment requires time away but provides the most intensive support for severe cases.
What is fentanyl and why is it so dangerous?
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine. A lethal dose is just 2 milligrams. It is increasingly found in the illicit drug supply, mixed into heroin, cocaine, methamphetamine, and counterfeit prescription pills — often without the user's knowledge. Fentanyl is now responsible for roughly 75% of all opioid overdose deaths in the United States. Treatment for fentanyl addiction typically requires MAT (often at higher buprenorphine or methadone doses), naloxone training, and comprehensive behavioral support.
How long does MAT treatment last?
There is no fixed duration for MAT — treatment length should be individualized. Research consistently shows that longer treatment produces better outcomes. The American Society of Addiction Medicine (ASAM) recommends a minimum of one year of MAT, and many addiction specialists recommend indefinite maintenance for people with severe OUD, as the risk of fatal overdose is highest in the period after discontinuing MAT. The decision to taper off medication should be made collaboratively with a treatment provider when the patient is stable, has strong support systems, and is not facing major life stressors.
Is fentanyl in the drug supply near me?
Almost certainly yes. Fentanyl has been detected in the illicit drug supply in all 50 states. It is routinely found in heroin, counterfeit prescription pills (especially fake oxycodone M30s, Xanax, and Adderall), cocaine, and methamphetamine. DEA lab testing shows that 7 out of 10 counterfeit pills seized contain a potentially lethal dose of fentanyl. Fentanyl test strips — which can detect fentanyl before use — are available for free from many harm reduction organizations, health departments, and community pharmacies. The safest assumption is that any illicit substance may contain fentanyl.
Medical Review and Sources
Trusted Resources
Substance Abuse and Mental Health Services Administration
Federal agency providing information, resources, and treatment locator for substance abuse and mental health.
Helpline: 1-800-662-4357
National Institute on Drug Abuse
NIH institute advancing science on drug use and addiction causes, consequences, and treatment.
National Institute on Alcohol Abuse and Alcoholism
NIH institute supporting research on alcohol's impact on health and providing treatment resources.
Ready To Start Opioid Treatment?
Opioid addiction is a medical condition — not a moral failure. Medication-assisted treatment saves lives. Speak with a specialist who can help you find the right MAT program, detox center, or residential facility — 100% free and confidential, available 24/7.
Browse opioid addiction programs in states with the most treatment options.
Related conditions, treatment approaches, and levels of care.